Lisa Lancaster

Vanderbilt University has awarded a new cycle of Innovation Catalyst Fund grants to pioneering faculty projects that advance health care technology, AI tools for research impact and wearable devices. These grants support translational research and drive real-world solutions across disciplines, underscoring Vanderbilt's commitment to fostering innovation and societal impact. Read More

The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF). Read More

Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases. Read More

Longtime treatment for IPF ineffective and even dangerous. Read More